NCT04182100: A trial that was reported late by PharmaEssentia Japan K.K.
This trial has reported, although it was 316 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04182100 |
|---|---|
| Title | Phase 2 Single Arm Study of Efficacy and Safety of P1101 for Polycythemia Vera (PV) Patients for Whom the Current Standard of Treatment is Difficult to Apply |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 20, 2019 |
| Completion date | March 8, 2021 |
| Required reporting date | March 8, 2022, midnight |
| Actual reporting date | Jan. 18, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 316 |